Treatment for Patent Foramen Ovale
Primary Recommendation
For patients under 60 years old with PFO and cryptogenic stroke after extensive workup excluding other causes, strongly pursue percutaneous PFO closure followed by antiplatelet therapy rather than antiplatelet therapy alone 1.
Treatment Algorithm Based on Clinical Context
1. PFO with Cryptogenic Stroke (Age <60)
This is the only well-established indication for PFO closure with high-quality evidence:
- First-line: PFO closure + antiplatelet therapy (strong recommendation, high-quality evidence) 1
- Provides substantial stroke reduction benefit
- Procedure takes <2 hours, 1-day hospital stay, full recovery within weeks
- Risk of device-related adverse events is low
- Small increased risk of persistent atrial fibrillation (5% vs 23% baseline)
If anticoagulation is NOT contraindicated:
- Weak recommendation for PFO closure + antiplatelet therapy over anticoagulation alone 1
- Rationale: Avoids long-term bleeding risk from anticoagulation while providing stroke protection
If PFO closure is contraindicated or declined:
- Weak recommendation for anticoagulation over antiplatelet therapy alone 1
2. Incidentally Discovered PFO (No Prior Stroke)
No intervention recommended - manage conservatively 2
- Asymptomatic PFO does not increase stroke risk
- Screening for primary prevention is not recommended 3
- No evidence supports closure in asymptomatic patients
3. Age >60 Years with Cryptogenic Stroke
Exercise caution - evidence is weaker in this population 1, 4:
- Fewer cryptogenic strokes are caused by paradoxical emboli in older patients
- Benefits of closure are smaller, harms potentially greater
- Traditional cerebrovascular risk factors (diabetes, hypertension, hyperlipidemia) make PFO less likely to be causative
- Consider medical therapy preferentially unless compelling anatomical features suggest PFO causation
4. Other Potential Indications (Weak/Controversial Evidence)
These require individualized assessment with multidisciplinary input 5:
- Systemic deoxygenation syndromes (platypnea-orthodeoxia): May consider closure in selected cases
- Decompression sickness in divers: May consider if PFO determined causative
- Migraine with aura: Evidence does NOT support routine closure 4, 6
- Transient ischemic attack (TIA): Weaker evidence than for completed stroke 4
Critical Diagnostic Requirements Before Treatment
Before considering any intervention, extensive workup must exclude other stroke etiologies 1:
- Complete evaluation for atrial fibrillation (prolonged monitoring)
- Carotid imaging
- Cardiac imaging for other sources of embolism
- Hypercoagulability workup
- Assessment of traditional vascular risk factors
Anatomical characterization matters 3:
- Large shunt size (~10mm diameter) increases likelihood of causation 7
- Atrial septal aneurysm presence
- Prominent Eustachian valve
- Large tunnel anatomy
- Must differentiate from atrial septal defect or pulmonary shunts 7
Post-Procedure Management
- Antiplatelet therapy continued after closure (duration varies, may be indefinite or discontinued months post-procedure) 1
- Monitor for atrial fibrillation development
- Assess for residual shunt with multimodality imaging 8
Key Pitfalls to Avoid
- Do not close PFO without exhaustive alternative stroke workup - cryptogenic designation requires negative extensive evaluation
- Do not routinely close PFO for migraine - evidence does not support this indication
- Be cautious in patients >60 - lower likelihood of PFO causation
- Do not screen asymptomatic patients - no role for primary prevention
- Recognize that not all strokes in PFO patients are PFO-related - coincidence is common given 25% population prevalence 6
Evidence Quality Note
The 2018 BMJ guideline 1 provides the strongest framework, based on high-quality evidence (GRADE methodology) specifically for cryptogenic stroke in younger patients. Recent research 9 from 2025 confirms significant stroke reduction with closure (7 RCTs, 4539 patients), though with increased atrial fibrillation risk. The evidence base for other indications remains insufficient to recommend routine closure 4, 6.